BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14617759)

  • 1. Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.
    Neff T; Horn PA; Peterson LJ; Thomasson BM; Thompson J; Williams DA; Schmidt M; Georges GE; von Kalle C; Kiem HP
    J Clin Invest; 2003 Nov; 112(10):1581-8. PubMed ID: 14617759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.
    Zielske SP; Reese JS; Lingas KT; Donze JR; Gerson SL
    J Clin Invest; 2003 Nov; 112(10):1561-70. PubMed ID: 14617757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selection and chemoprotection after drug resistance gene therapy in a nonmyeloablative allogeneic transplantation setting in dogs.
    Gerull S; Beard BC; Peterson LJ; Neff T; Kiem HP
    Hum Gene Ther; 2007 May; 18(5):451-6. PubMed ID: 17536975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
    Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
    J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients.
    Beard BC; Sud R; Keyser KA; Ironside C; Neff T; Gerull S; Trobridge GD; Kiem HP
    Blood; 2009 May; 113(21):5094-103. PubMed ID: 19336761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy.
    Neff T; Beard BC; Peterson LJ; Anandakumar P; Thompson J; Kiem HP
    Blood; 2005 Feb; 105(3):997-1002. PubMed ID: 15494421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylguanine DNA methyltransferase-mediated drug resistance-based selective enrichment and engraftment of transplanted stem cells in skeletal muscle.
    Lee AS; Kahatapitiya P; Kramer B; Joya JE; Hook J; Liu R; Schevzov G; Alexander IE; McCowage G; Montarras D; Gunning PW; Hardeman EC
    Stem Cells; 2009 May; 27(5):1098-108. PubMed ID: 19415780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transduction and amplification in large animal models.
    Trobridge G; Beard BC; Kiem HP
    Hum Gene Ther; 2005 Dec; 16(12):1355-66. PubMed ID: 16390267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
    Cornetta K; Croop J; Dropcho E; Abonour R; Kieran MW; Kreissman S; Reeves L; Erickson LC; Williams DA
    Cancer Gene Ther; 2006 Sep; 13(9):886-95. PubMed ID: 16645619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.
    Baum C; Eckert HG; Stockschläder M; Just U; Hegewisch-Becker S; Hildinger M; Uhde A; John J; Ostertag W
    J Hematother; 1996 Aug; 5(4):323-9. PubMed ID: 8877707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell.
    Li Z; Fehse B; Schiedlmeier B; Düllmann J; Frank O; Zander AR; Ostertag W; Baum C
    Leukemia; 2002 Sep; 16(9):1655-63. PubMed ID: 12200677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector.
    Kiem HP; McSweeney PA; Bruno B; Goerner M; Buron G; Morris J; Storb R; Miller AD
    Gene Ther; 1999 Jun; 6(6):966-72. PubMed ID: 10455398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection.
    Trobridge GD; Wu RA; Beard BC; Chiu SY; Muñoz NM; von Laer D; Rossi JJ; Kiem HP
    PLoS One; 2009 Nov; 4(11):e7693. PubMed ID: 19888329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.
    Milsom MD; Williams DA
    DNA Repair (Amst); 2007 Aug; 6(8):1210-21. PubMed ID: 17482893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning.
    Huhn RD; Tisdale JF; Agricola B; Metzger ME; Donahue RE; Dunbar CE
    Hum Gene Ther; 1999 Jul; 10(11):1783-90. PubMed ID: 10446918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.
    Beard BC; Trobridge GD; Ironside C; McCune JS; Adair JE; Kiem HP
    J Clin Invest; 2010 Jul; 120(7):2345-54. PubMed ID: 20551514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy.
    Grund N; Maier P; Giordano FA; Appelt JU; Zucknick M; Li L; Wenz F; Zeller WJ; Fruehauf S; Allgayer H; Laufs S
    Hum Gene Ther; 2010 Aug; 21(8):943-56. PubMed ID: 20210626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection.
    Davis BM; Koç ON; Gerson SL
    Blood; 2000 May; 95(10):3078-84. PubMed ID: 10807772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
    Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
    Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.